140 related articles for article (PubMed ID: 20091489)
21. O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.
Yu G; Zhang Y; Meng B; Xie X; Wang Z; Ying W; Lv J; Zhang H
Nephrol Dial Transplant; 2021 Dec; 37(1):33-41. PubMed ID: 34152412
[TBL] [Abstract][Full Text] [Related]
22. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy.
Greer MR; Barratt J; Harper SJ; Allen AC; Feehally J
Nephrol Dial Transplant; 1998 Aug; 13(8):1980-3. PubMed ID: 9719151
[TBL] [Abstract][Full Text] [Related]
23. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
24. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
Ohyama Y; Yamaguchi H; Nakajima K; Mizuno T; Fukamachi Y; Yokoi Y; Tsuboi N; Inaguma D; Hasegawa M; Renfrow MB; Novak J; Yuzawa Y; Takahashi K
Sci Rep; 2020 Jan; 10(1):671. PubMed ID: 31959827
[TBL] [Abstract][Full Text] [Related]
25. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
[TBL] [Abstract][Full Text] [Related]
26. No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients.
Malycha F; Eggermann T; Hristov M; Schena FP; Mertens PR; Zerres K; Floege J; Eitner F
Nephrol Dial Transplant; 2009 Jan; 24(1):321-4. PubMed ID: 18840896
[TBL] [Abstract][Full Text] [Related]
27. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
[TBL] [Abstract][Full Text] [Related]
28. Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region.
Hiki Y; Hori H; Yamamoto K; Yamamoto Y; Yuzawa Y; Kitaguchi N; Takahashi K
J Nephrol; 2015 Apr; 28(2):181-6. PubMed ID: 25037591
[TBL] [Abstract][Full Text] [Related]
29. Development of an enrichment-free one-pot sample preparation and ultra-high performance liquid chromatography-tandem mass spectrometry method to identify Immunoglobulin A1 hinge region O-glycoforms for Immunoglobulin A nephropathy.
Chen HF; Kao CC; Ka SM; Wang SY; Chen MX; Chen GY; Weng TI; Lai RY; Yeh SC; Lin YC; Chen HH; Chang WC; Wu MS; Tsai IL
J Chromatogr A; 2022 Dec; 1685():463589. PubMed ID: 36351322
[TBL] [Abstract][Full Text] [Related]
30. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
31. Separation of Two Distinct O-Glycoforms of Human IgA1 by Serial Lectin Chromatography Followed by Mass Spectrometry O-Glycan Analysis.
Lehoux S; Ju T
Methods Enzymol; 2017; 585():61-75. PubMed ID: 28109443
[TBL] [Abstract][Full Text] [Related]
32. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
Renfrow MB; Cooper HJ; Tomana M; Kulhavy R; Hiki Y; Toma K; Emmett MR; Mestecky J; Marshall AG; Novak J
J Biol Chem; 2005 May; 280(19):19136-45. PubMed ID: 15728186
[TBL] [Abstract][Full Text] [Related]
33. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
34. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
35. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
[TBL] [Abstract][Full Text] [Related]
36. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy.
Renfrow MB; Mackay CL; Chalmers MJ; Julian BA; Mestecky J; Kilian M; Poulsen K; Emmett MR; Marshall AG; Novak J
Anal Bioanal Chem; 2007 Nov; 389(5):1397-407. PubMed ID: 17712550
[TBL] [Abstract][Full Text] [Related]
37. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
38. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
39. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum.
Iwanami N; Iwase H; Takahashi N; Kato K; Itoh A; Takatani T; Makita S; Kobayashi Y; Okamoto M; Nakamura S; Hiki Y; Ishii M
J Nephrol; 2008; 21(1):118-26. PubMed ID: 18264945
[TBL] [Abstract][Full Text] [Related]
40. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients.
Iwase H; Katsumata T; Itoh A; Hiki Y; Ikuko N; Sano T; Takatani T; Kobayashi Y
J Nephrol; 2002; 15(6):703-8. PubMed ID: 12495288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
